Articles - 3iw8 mentioned but not cited (3)
- The design and application of target-focused compound libraries. Harris CJ, Hill RD, Sheppard DW, Slater MJ, Stouten PF. Comb Chem High Throughput Screen 14 521-531 (2011)
- p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma. Yang L, Sun X, Ye Y, Lu Y, Zuo J, Liu W, Elcock A, Zhu S. Front Oncol 9 1294 (2019)
- Fragment-Based Structural Optimization of a Natural Product Itampolin A as a p38α Inhibitor for Lung Cancer. Liang JW, Wang MY, Wang S, Li XY, Meng FH. Mar Drugs 17 53 (2019)
Reviews citing this publication (5)
- Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery? Zhao Z, Wu H, Wang L, Liu Y, Knapp S, Liu Q, Gray NS. ACS Chem Biol 9 1230-1241 (2014)
- Proteus in the world of proteins: conformational changes in protein kinases. Rabiller M, Getlik M, Klüter S, Richters A, Tückmantel S, Simard JR, Rauh D. Arch Pharm (Weinheim) 343 193-206 (2010)
- Fluorescent biosensors for high throughput screening of protein kinase inhibitors. Prével C, Pellerano M, Van TN, Morris MC. Biotechnol J 9 253-265 (2014)
- Fluorescent Reporters and Biosensors for Probing the Dynamic Behavior of Protein Kinases. González-Vera JA, Morris MC. Proteomes 3 369-410 (2015)
- A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors. Astolfi A, Iraci N, Manfroni G, Barreca ML, Cecchetti V. ChemMedChem 10 957-969 (2015)
Articles citing this publication (23)
- Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors. Williams AB, Nguyen B, Li L, Brown P, Levis M, Leahy D, Small D. Leukemia 27 48-55 (2013)
- A Systematic Review of Recently Reported Marine Derived Natural Product Kinase Inhibitors. Li T, Wang N, Zhang T, Zhang B, Sajeevan TP, Joseph V, Armstrong L, He S, Yan X, Naman CB. Mar Drugs 17 E493 (2019)
- Light-assisted small-molecule screening against protein kinases. Inglés-Prieto Á, Reichhart E, Muellner MK, Nowak M, Nijman SM, Grusch M, Janovjak H. Nat Chem Biol 11 952-954 (2015)
- Insights into MAPK p38alpha DFG flip mechanism by accelerated molecular dynamics. Filomia F, De Rienzo F, Menziani MC. Bioorg Med Chem 18 6805-6812 (2010)
- Mechanism of kinase inactivation and nonbinding of FRATide to GSK3β due to K85M mutation: molecular dynamics simulation and normal mode analysis. Lu S, Jiang Y, Lv J, Zou J, Wu T. Biopolymers 95 669-681 (2011)
- Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK. Halekotte J, Witt L, Ianes C, Krüger M, Bührmann M, Rauh D, Pichlo C, Brunstein E, Luxenburger A, Baumann U, Knippschild U, Bischof J, Peifer C. Molecules 22 E522 (2017)
- Identification of type-II inhibitors using kinase structures. Lovering F, McDonald J, Whitlock GA, Glossop PA, Phillips C, Bent A, Sabnis Y, Ryan M, Fitz L, Lee J, Chang JS, Han S, Kurumbail R, Thorarensen A. Chem Biol Drug Des 80 657-664 (2012)
- Discovery of allosteric modulators for GABAA receptors by ligand-directed chemistry. Yamaura K, Kiyonaka S, Numata T, Inoue R, Hamachi I. Nat Chem Biol 12 822-830 (2016)
- Structure- and ligand-based drug design of novel p38-alpha MAPK inhibitors in the fight against the Alzheimer's disease. Pinsetta FR, Taft CA, de Paula da Silva CH. J Biomol Struct Dyn 32 1047-1063 (2014)
- Allosteric inhibition of Taspase1's pathobiological activity by enforced dimerization in vivo. Bier C, Knauer SK, Wünsch D, Kunst L, Scheiding S, Kaiser M, Ottmann C, Krämer OH, Stauber RH. FASEB J 26 3421-3429 (2012)
- The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC. Gill K, Nigam L, Singh R, Kumar S, Subbarao N, Chauhan SS, Dey S. PLoS One 9 e101525 (2014)
- Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way. Uitdehaag JC, Sünnen CM, van Doornmalen AM, de Rouw N, Oubrie A, Azevedo R, Ziebell M, Nickbarg E, Karstens WJ, Ruygrok S. J Biomol Screen 16 1007-1017 (2011)
- Oxidative condensations to form benzimidazole-substituted potassium organotrifluoroborates. Molander GA, Ajayi K. Org Lett 14 4242-4245 (2012)
- Structural modeling of GSK3β implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs. Balasubramaniam M, Mainali N, Bowroju SK, Atluri P, Penthala NR, Ayyadevera S, Crooks PA, Shmookler Reis RJ. Sci Rep 10 18326 (2020)
- p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening. Astolfi A, Iraci N, Sabatini S, Barreca ML, Cecchetti V. Molecules 20 15842-15861 (2015)
- Structure-based design, synthesis and crystallization of 2-arylquinazolines as lipid pocket ligands of p38α MAPK. Bührmann M, Wiedemann BM, Müller MP, Hardick J, Ecke M, Rauh D. PLoS One 12 e0184627 (2017)
- Characterization of interactions and pharmacophore development for DFG-out inhibitors to RET tyrosine kinase. Gao C, Grøtli M, Eriksson LA. J Mol Model 21 167 (2015)
- Interaction investigations of HipA binding to HipB dimer and HipB dimer + DNA complex: a molecular dynamics simulation study. Li C, Wang Y, Wang Y, Chen G. J Mol Recognit 26 556-567 (2013)
- Druggable exosites of the human kino-pocketome. Nicola G, Kufareva I, Ilatovskiy AV, Abagyan R. J Comput Aided Mol Des 34 219-230 (2020)
- Fluorescent-responsive synthetic C1b domains of protein kinase Cδ as reporters of specific high-affinity ligand binding. Ohashi N, Nomura W, Narumi T, Lewin NE, Itotani K, Blumberg PM, Tamamura H. Bioconjug Chem 22 82-87 (2011)
- Identification of a selective inhibitor of transforming growth factor β-activated kinase 1 by biosensor-based screening of focused libraries. Miura T, Matsuo A, Muraoka T, Ide M, Morikami K, Kamikawa T, Nishihara M, Kashiwagi H. Bioorg Med Chem Lett 27 1031-1036 (2017)
- Application of particle swarm optimization to understand the mechanism of action of allosteric inhibitors of the enzyme HSD17β13. Ford A, Breitgoff F, Pasquini M, MacKenzie A, McElroy S, Baker S, Abrusci P, Varzandeh S, Bird L, Gavard A, Damerell D, Redhead M. Patterns (N Y) 4 100733 (2023)
- Monitoring Conformational Changes in the Receptor Tyrosine Kinase EGFR. Becker C, Öcal S, Nguyen HD, Phan T, Keul M, Simard JR, Rauh D. Chembiochem 17 990-994 (2016)